ZIM
BSX icon

Zacks Investment Management’s Boston Scientific BSX Stock Holding History

Zacks Investment Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$242K Sell
5,681
-251,448
-98% -$13.7M ﹤0.01% 646
2026
Q1 		$16.1M Buy
257,129
+1,439
+0.6% +$115K 0.13% 144
2025
Q4 		$24.4M Buy
255,690
+7,944
+3% +$779K 0.19% 123
2025
Q3 		$24.2M Buy
247,746
+795
+0.3% +$82.3K 0.19% 123
2025
Q2 		$26.5M Buy
246,951
+428
+0.2% +$43.3K 0.23% 113
2025
Q1 		$24.9M Buy
246,523
+6,929
+3% +$698K 0.23% 111
2024
Q4 		$21.4M Sell
239,594
-16,224
-6% -$1.43M 0.2% 120
2024
Q3 		$21.4M Buy
255,818
+17,891
+8% +$1.41M 0.19% 128
2024
Q2 		$18.3M Buy
237,927
+79,252
+50% +$5.8M 0.21% 116
2024
Q1 		$10.9M Buy
+158,675
New +$10.2M 0.12% 150
2020
Q1 		– Sell
-5,128
Closed -$232K – 504
2019
Q4 		$232K Buy
+5,128
New +$215K ﹤0.01% 507
2017
Q1 		– Sell
-16,190
Closed -$350K – 645
2016
Q4 		$350K Hold
16,190
– – 0.01% 482
2016
Q3 		$385K Buy
+16,190
New +$386K 0.01% 473

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Zacks Investment Management's BSX Position: Q2 2026 in Review

Zacks Investment Management reduced its Boston Scientific (BSX) stake by 98% in Q2 2026, selling an estimated $13.7M and leaving 5,681 shares worth $242K. The position accounts for ﹤0.01% of the portfolio, ranked #646.

Zacks Investment Management first reported a position in BSX in Q3 2016 and has held it in 13 quarters since. The position peaked at $26.5M in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Zacks Investment Management held 5,681 shares of Boston Scientific worth $242K as of Q2 2026.
  • Zacks Investment Management sold 251,448 Boston Scientific shares in Q2 2026, an estimated $13.7M.
  • Boston Scientific made up ﹤0.01% of Zacks Investment Management's portfolio in Q2 2026, its #646 holding.
  • Zacks Investment Management first reported a position in Boston Scientific in Q3 2016 and has held it in 13 quarters since.
  • Zacks Investment Management's Boston Scientific position peaked at $26.5M in Q2 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Zacks Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.